Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP)
The ideal goal of anticoagulant therapy is to attenuate thrombosis without compromising hemostasis. Although newer oral anticoagulants such as apixaban, rivaroxaban, and edoxaban are associated with less intracranial hemorrhage than vitamin K antagonists, bleeding remains their major side effect…
Moderator
Medical Director, Coagulation, Quest Diagnostics
Speakers
Professor of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center
Professor of Hematology, Tel Aviv University